Healthcare provider profile · identity verified

Christopher R Matson, DO

Family Practice · DES MOINES, IA · NPI 1538368170

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	469	113
Omeprazole	Omeprazole	434	87
Atorvastatin Calcium	Atorvastatin Calcium	409	109
Lisinopril	Lisinopril	405	93
Albuterol Sulfate Hfa	Albuterol Sulfate	277	75
Gabapentin	Gabapentin	251	52
Levothyroxine Sodium	Levothyroxine Sodium	226	47
Metoprolol Succinate	Metoprolol Succinate	199	45
Hydrochlorothiazide	Hydrochlorothiazide	190	45
Metformin Hcl Er	Metformin Hcl	187	43
Tamsulosin Hcl	Tamsulosin Hcl	181	42
Losartan Potassium	Losartan Potassium	177	38
Metoprolol Tartrate	Metoprolol Tartrate	172	33
Metformin Hcl	Metformin Hcl	171	42
Potassium Chloride	Potassium Chloride	164	30
Rosuvastatin Calcium	Rosuvastatin Calcium	164	30
Furosemide	Furosemide	163	37
Pantoprazole Sodium	Pantoprazole Sodium	150	30
Tramadol Hcl	Tramadol Hcl	142	27
Famotidine	Famotidine	140	33
Fluticasone Propionate	Fluticasone Propionate	134	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	125	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	123	27
Baclofen	Baclofen	111	27
Ozempic	Semaglutide	102	14
Ventolin Hfa	Albuterol Sulfate	100	19
Symbicort	Budesonide/Formoterol Fumarate	89	15
Amitriptyline Hcl	Amitriptyline Hcl	80	17
Pravastatin Sodium	Pravastatin Sodium	80	15
Meloxicam	Meloxicam	78	18
Ibuprofen	Ibuprofen	77	15
Diclofenac Sodium	Diclofenac Sodium	75	20
Naproxen	Naproxen	74	21
Clopidogrel	Clopidogrel Bisulfate	72	15
Trazodone Hcl	Trazodone Hcl	67	14
Triamcinolone Acetonide	Triamcinolone Acetonide	66	36
Escitalopram Oxalate	Escitalopram Oxalate	64	14
Zolpidem Tartrate	Zolpidem Tartrate	60	11
Clonazepam	Clonazepam	59	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	18
Tizanidine Hcl	Tizanidine Hcl	59	16
Spironolactone	Spironolactone	58	14
Xarelto	Rivaroxaban	56	suppressed
Glimepiride	Glimepiride	55	17
Buspirone Hcl	Buspirone Hcl	51	suppressed
Ropinirole Hcl	Ropinirole Hcl	51	13
Allopurinol	Allopurinol	50	suppressed
Trulicity	Dulaglutide	49	suppressed
Warfarin Sodium	Warfarin Sodium	49	suppressed
Bumetanide	Bumetanide	45	suppressed
Simvastatin	Simvastatin	45	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	11
Sertraline Hcl	Sertraline Hcl	41	suppressed
Glipizide	Glipizide	40	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Pregabalin	Pregabalin	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Spiriva Handihaler	Tiotropium Bromide	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Eliquis	Apixaban	33	suppressed
Ondansetron Odt	Ondansetron	33	12
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	32	suppressed
Sulindac	Sulindac	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Alprazolam	Alprazolam	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	12
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Levemir Flexpen	Insulin Detemir	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Atenolol	Atenolol	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Novolin R	Insulin Regular, Human	19	suppressed
Prednisone	Prednisone	19	17
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Azithromycin	Azithromycin	16	15
Doxycycline Monohydrate	Doxycycline Monohydrate	16	11
Lovastatin	Lovastatin	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Mupirocin	Mupirocin	15	12
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Betamethasone Valerate	Betamethasone Valerate	14	suppressed
Finasteride	Finasteride	14	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	11
Chlorthalidone	Chlorthalidone	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error